We analyze noise-free headlines and recent hype associated with CVS Health Corporation which may create opportunities for some arbitrage if properly timed. With CVS Health hype-based prediction module you can estimate the value of CVS Health Corporation from the prospective of CVS Health response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on CVS Health over a specific investment horizon. Check also Trending Equities.
On 20 of February CVS Health is traded for 64.36. The entity has historical hype elasticity of -0.06 and average elasticity to hype of competition of 0.06. CVS Health Corporation is estimated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 398.33%. The immediate return on the next news is estimated to be very small where as daily expected return is currently at 0.1%. The volatility of relative hype elasticity to CVS Health is about 424.51%%. The volatility of related hype on CVS Health is about 424.51% with expected price after next announcement by competition of 64.42. About 71.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. CVS Health has Price/Earnings To Growth (PEG) ratio of 0.76. The entity last dividend was issued on 2019-01-24. The firm had 2:1 split on 2005-06-07. Considering 30-days investment horizon, the next estimated press release will be in about 6 days. Check also Trending Equities.